6,950 Shares in GE HealthCare Technologies Inc. $GEHC Bought by Private Wealth Partners LLC

Private Wealth Partners LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the third quarter, Holdings Channel reports. The fund acquired 6,950 shares of the company’s stock, valued at approximately $522,000.

Several other hedge funds also recently added to or reduced their stakes in the stock. Dodge & Cox lifted its position in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares during the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies during the second quarter valued at approximately $468,120,000. Holocene Advisors LP lifted its holdings in GE HealthCare Technologies by 178.5% during the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after buying an additional 2,581,522 shares during the last quarter. Menora Mivtachim Holdings LTD. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $80,755,000. Finally, Balyasny Asset Management L.P. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter worth approximately $58,388,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 0.2%

GEHC stock opened at $78.97 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm’s 50-day simple moving average is $82.63 and its 200 day simple moving average is $77.35. The stock has a market cap of $35.97 billion, a PE ratio of 16.32, a price-to-earnings-growth ratio of 2.38 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same period in the previous year, the business posted $1.14 EPS. GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on GEHC shares. BTIG Research reissued a “buy” rating and set a $87.00 price target on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Jefferies Financial Group increased their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price target for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Evercore ISI reaffirmed an “outperform” rating and set a $95.00 price objective on shares of GE HealthCare Technologies in a research report on Monday, January 5th. Finally, Barclays initiated coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price on the stock. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Hold” and an average price target of $90.33.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.